Literature DB >> 18340509

Off-pump coronary artery bypass grafting using in situ bilateral skeletonized internal thoracic arteries.

Tomoaki Suzuki1, Tohru Asai, Keiji Matsubayashi, Atsushi Kambara, Hirohisa Ikegami, Takeshi Kinoshita, Osamu Nishimura.   

Abstract

OBJECTIVE: All arterial off-pump coronary artery bypass grafting (OPCAB) with in situ bilateral skeletonized internal thoracic arteries (ITAs) may become a standard procedure that would provide better long-term results without affecting early results.
METHODS: Our study included 404 consecutive patients who underwent OPCAB with one or two ITAs. We compared the clinical results of 135 patients who underwent OPCAB using unilateral ITA (UITA group) to those of 269 patients using bilateral ITAs (BITA group).
RESULTS: The average number of distal anastomoses was 3.07 in the UITA group and 3.47 in the BITA group (P < 0.01). Four operative mortalities occurred in the UITA group and two in the BITA group. There were no significant differences in morbidity between the two groups.
CONCLUSION: OPCAB using bilateral skeletonized ITAs is technically feasible, with good early results. Arterial OPCAB using in situ bilateral skeletonized ITAs may become a standard procedure in the future.

Entities:  

Mesh:

Year:  2008        PMID: 18340509     DOI: 10.1007/s11748-007-0203-x

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  19 in total

1.  Two internal thoracic artery grafts are better than one.

Authors:  B W Lytle; E H Blackstone; F D Loop; P L Houghtaling; J H Arnold; R Akhrass; P M McCarthy; D M Cosgrove
Journal:  J Thorac Cardiovasc Surg       Date:  1999-05       Impact factor: 5.209

2.  Does bilateral internal mammary artery grafting increase surgical risk?

Authors:  D M Cosgrove; B W Lytle; F D Loop; P C Taylor; R W Stewart; C C Gill; L A Golding; M Goormastic
Journal:  J Thorac Cardiovasc Surg       Date:  1988-05       Impact factor: 5.209

3.  Does bilateral internal thoracic artery grafting increase surgical risk in diabetic patients?

Authors:  M S Uva; E Braunberger; M Fisher; Y Fromes; P H Deleuze; J A Celestin; O M Bical
Journal:  Ann Thorac Surg       Date:  1998-12       Impact factor: 4.330

4.  Long-term results of bilateral internal thoracic artery grafting.

Authors:  M Ura; R Sakata; Y Nakayama; Y Arai; T Saito
Journal:  Ann Thorac Surg       Date:  2000-12       Impact factor: 4.330

5.  Bilateral skeletonized internal thoracic artery graftings in off-pump coronary artery bypass: early result of Y versus in situ grafts.

Authors:  Ki-Bong Kim; Kwang Ree Cho; Woo-Ik Chang; Cheong Lim; Byung Moon Ham; Yong Lak Kim
Journal:  Ann Thorac Surg       Date:  2002-10       Impact factor: 4.330

6.  Feasibility and suitability of the routine use of bilateral internal thoracic arteries.

Authors:  Takashi Hirotani; Shogo Shirota; Yasunori Cho; Shigeyuki Takeuchi
Journal:  Ann Thorac Surg       Date:  2002-02       Impact factor: 4.330

7.  Early results of coronary grafting using ultrasonically skeletonized internal thoracic arteries.

Authors:  T Higami; T Yamashita; H Nohara; K Iwahashi; T Shida; K Ogawa
Journal:  Ann Thorac Surg       Date:  2001-04       Impact factor: 4.330

8.  Inflammatory response after coronary revascularization with or without cardiopulmonary bypass.

Authors:  R Ascione; C T Lloyd; M J Underwood; A A Lotto; A A Pitsis; G D Angelini
Journal:  Ann Thorac Surg       Date:  2000-04       Impact factor: 4.330

9.  Better ischemic event-free survival after two internal thoracic artery grafts: 13 years of follow-up.

Authors:  E Berreklouw; P P Rademakers; J M Koster; L van Leur; B J van der Wielen; P Westers
Journal:  Ann Thorac Surg       Date:  2001-11       Impact factor: 4.330

10.  Assessment of sternal vascularity with single photon emission computed tomography after harvesting of the internal thoracic artery.

Authors:  A J Cohen; J Lockman; M Lorberboym; O Bder; N Cohen; B Medalion; A Schachner
Journal:  J Thorac Cardiovasc Surg       Date:  1999-09       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.